Sean Bohen's most recent trade in Olema Pharmaceuticals Inc was a trade of 650,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Olema Pharmaceuticals Inc | Sean P. Bohen | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 650,000 | 650,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Sean P. Bohen | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 204,750 | 351,164 | - | 0 | Common Stock | |
| Olema Pharmaceuticals Inc | Sean P. Bohen | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 8.66 per share. | 09 Dec 2024 | 55,907 | 242,929 | - | 8.7 | 484,155 | Common Stock |
| Olema Pharmaceuticals Inc | Sean P. Bohen | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 9.37 per share. | 09 Dec 2024 | 52,328 | 298,836 | - | 9.4 | 490,313 | Common Stock |
| Olema Pharmaceuticals Inc | Sean P. Bohen | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 9.39 per share. | 09 Dec 2024 | 1,267 | 241,662 | - | 9.4 | 11,897 | Common Stock |
| Olema Pharmaceuticals Inc | Bohen Sean P. | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 621,500 | 621,500 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Sean P. Bohen | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2023 | 110,250 | 202,150 | - | 0 | Common Stock | |
| Olema Pharmaceuticals Inc | Sean P. Bohen | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 13.90 per share. | 20 Nov 2023 | 27,932 | 144,925 | - | 13.9 | 388,255 | Common Stock |
| Olema Pharmaceuticals Inc | Sean P. Bohen | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 14.84 per share. | 20 Nov 2023 | 26,691 | 175,459 | - | 14.8 | 396,094 | Common Stock |
| Olema Pharmaceuticals Inc | Sean P. Bohen | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 15.29 per share. | 20 Nov 2023 | 2,602 | 172,857 | - | 15.3 | 39,785 | Common Stock |
| Olema Pharmaceuticals Inc | Sean Bohen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 550,000 | 550,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Sean Bohen | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Sep 2022 | 20,000 | 74,279 | - | - | Common Stock | |
| Olema Pharmaceuticals Inc | Sean Bohen | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 812,250 | 812,250 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Sean Bohen | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Oct 2021 | 5,000 | 966,316 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Sean Bohen | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.82 per share. | 14 Oct 2021 | 5,000 | 57,514 | - | 4.8 | 24,120 | Common Stock |
| Olema Pharmaceuticals Inc | Sean Bohen | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 30.42 per share. | 14 Oct 2021 | 4,649 | 52,865 | - | 30.4 | 141,423 | Common Stock |
| Olema Pharmaceuticals Inc | Sean Bohen | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 31.17 per share. | 14 Oct 2021 | 351 | 52,514 | - | 31.2 | 10,941 | Common Stock |
| Olema Pharmaceuticals Inc | Sean Bohen | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 30.07 per share. | 27 Sep 2021 | 1,085 | 52,514 | - | 30.1 | 32,626 | Common Stock |
| Olema Pharmaceuticals Inc | Sean Bohen | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Sep 2021 | 1,085 | 971,316 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Sean Bohen | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.82 per share. | 27 Sep 2021 | 1,085 | 53,599 | - | 4.8 | 5,234 | Common Stock |
| Olema Pharmaceuticals Inc | Sean Bohen | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.82 per share. | 07 Sep 2021 | 2,631 | 56,905 | - | 4.8 | 12,692 | Common Stock |
| Olema Pharmaceuticals Inc | Sean Bohen | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 07 Sep 2021 | 2,631 | 52,514 | - | 30 | 78,930 | Common Stock |
| Olema Pharmaceuticals Inc | Sean Bohen | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Sep 2021 | 2,631 | 972,401 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Sean Bohen | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.82 per share. | 07 Sep 2021 | 413 | 54,687 | - | 4.8 | 1,992 | Common Stock |
| Olema Pharmaceuticals Inc | Sean Bohen | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 30.08 per share. | 07 Sep 2021 | 413 | 54,274 | - | 30.1 | 12,423 | Common Stock |
| Olema Pharmaceuticals Inc | Sean Bohen | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Sep 2021 | 413 | 975,032 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Sean Bohen | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.82 per share. | 01 Sep 2021 | 871 | 55,145 | - | 4.8 | 4,202 | Common Stock |
| Olema Pharmaceuticals Inc | Sean Bohen | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 30.05 per share. | 01 Sep 2021 | 871 | 54,274 | - | 30.1 | 26,174 | Common Stock |
| Olema Pharmaceuticals Inc | Sean Bohen | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2021 | 871 | 975,445 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Sean Bohen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2021 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Sean Bohen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2020 | 1,027,965 | 1,027,965 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Sean Bohen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2020 | 538,020 | 538,020 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Sean Bohen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2020 | 82,931 | 82,931 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Sean Bohen | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Sep 2020 | 51,649 | 976,316 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Sean Bohen | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.82 per share. | 19 Sep 2020 | 51,649 | 51,649 | - | 4.8 | 249,155 | Common Stock |